Although we detected an upregulation of H19 and downregulation of IGF2 and miR-675 in higher-risk MDS compared to lower-risk disease (Figure 5A), the levels of H19 did not directly correlate with either IGF2 or miR-675 when analyzed in the whole cohort. The gene discussed is H19; the disease is myelodysplastic syndrome.